""It's hard not to feel like pulling guidance and cutting the stock in half is a failure. We've watched a new normal unfold in terms of how many different pressures there are on the system and the magnitude of the change we're facing.""
"Centene is the country's biggest Medicaid insurer, with more than half of its revenue coming from Medicaid, while the rest is divided between Medicare and Marketplace plans."
Sarah London, CEO of Centene, leads the company through challenging times in U.S. health care, marked by funding cuts and rising costs. Despite a 20% revenue growth to $194.8 billion, Centene reported a net loss of $6.7 billion due to a write-down linked to the One Big Beautiful Bill Act. This law significantly reduces federal Medicaid spending and alters ACA Marketplace eligibility. London has withdrawn earnings guidance, resulting in a 40% drop in share price. She is transforming Centene's operations to adapt to these pressures.
Read at Fortune
Unable to calculate read time
Collection
[
|
...
]